MAMLUK RONI enters REDHILL BIOPHARMA LTD. with 103.50M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001178913-26-001285
103.50M
Baseline shares
100% direct
103.50M
Direct ownership
1 position
613.50M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned103.50M
Total
103.50M direct103.50M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 103.50M | Direct |
| Total | 103.50M | 103.50M direct |
Derivative Holdings1
American Depositary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
613.50M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
613.50M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| American Depositary Shares Direct | Ordinary Shares | — | — | 613.50M | N/A | |
| Total | 613.50M | 0.00 | ||||